Grand Pharmaceutical Group バランスシートの健全性
財務の健全性 基準チェック /66
Grand Pharmaceutical Group has a total shareholder equity of HK$15.9B and total debt of HK$4.5B, which brings its debt-to-equity ratio to 28.1%. Its total assets and total liabilities are HK$24.9B and HK$9.0B respectively. Grand Pharmaceutical Group's EBIT is HK$3.0B making its interest coverage ratio 17.8. It has cash and short-term investments of HK$3.2B.
主要情報
28.1%
負債資本比率
HK$4.47b
負債
| インタレスト・カバレッジ・レシオ | 17.8x |
| 現金 | HK$3.23b |
| エクイティ | HK$15.90b |
| 負債合計 | HK$9.00b |
| 総資産 | HK$24.90b |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: 512's short term assets (HK$8.2B) exceed its short term liabilities (HK$6.4B).
長期負債: 512's short term assets (HK$8.2B) exceed its long term liabilities (HK$2.6B).
デット・ツー・エクイティの歴史と分析
負債レベル: 512's net debt to equity ratio (7.8%) is considered satisfactory.
負債の削減: 512's debt to equity ratio has reduced from 29.4% to 28.1% over the past 5 years.
債務返済能力: 512's debt is well covered by operating cash flow (42.6%).
インタレストカバレッジ: 512's interest payments on its debt are well covered by EBIT (17.8x coverage).